News
ALPS
0.9701
-2.01%
-0.0199
Weekly Report: what happened at ALPS last week (0330-0403)?
Weekly Report · 2d ago
Weekly Report: what happened at ALPS last week (0323-0327)?
Weekly Report · 03/30 10:45
Alps Group files Form 3 initial beneficial ownership statement for Chief Vaccine Development Officer Poh Chit Laa
Reuters · 03/25 00:57
Alps Group director Chua Boon Ping files initial beneficial ownership statement
Reuters · 03/25 00:57
Alps Group director Chew Yoke Ling files initial beneficial ownership statement
Reuters · 03/25 00:56
Alps Group CFO Cheing Lye-Ping files initial beneficial ownership statement
Reuters · 03/25 00:56
Weekly Report: what happened at ALPS last week (0316-0320)?
Weekly Report · 03/23 10:40
Alps Group director Mohamed Suleiman bin files initial beneficial ownership statement
Reuters · 03/21 00:09
Alps Group Inc. files initial beneficial ownership statement for Chief Scientific Officer Manickam Ravichandran
Reuters · 03/21 00:06
Alps Group COO Low Wei Sim files initial beneficial ownership statement
Reuters · 03/21 00:05
Alps Group Inc. CEO Tham Seng Kong files initial beneficial ownership statement
Reuters · 03/21 00:04
Weekly Report: what happened at ALPS last week (0309-0313)?
Weekly Report · 03/16 10:39
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 03/12 21:05
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 03/12 17:05
Weekly Report: what happened at ALPS last week (0302-0306)?
Weekly Report · 03/09 10:39
Weekly Report: what happened at ALPS last week (0223-0227)?
Weekly Report · 03/02 10:38
Alps Group Publishes Peer-Reviewed Data Backing Safety of Novel NK Cell Therapy Platform
TipRanks · 02/23 14:28
Alps Group Inc. Reports Clinical Safety Data for Autologous NK Cell Infusions
Reuters · 02/23 13:00
Weekly Report: what happened at ALPS last week (0216-0220)?
Weekly Report · 02/23 10:38
Weekly Report: what happened at ALPS last week (0209-0213)?
Weekly Report · 02/16 10:38
More
Webull provides a variety of real-time ALPS stock news. You can receive the latest news about Alps Group Inc. through multiple platforms. This information may help you make smarter investment decisions.
About ALPS
Alps Group Inc is the parent company of Alps Life Sciences Inc., an integrated biotechnology platform integrating research and development, medical services, and wellness solutions of advanced therapies under one unified ecosystem aimed at improving healthcare outcomes globally. The Company has cultivated a diverse pipeline covering various biotechnology research areas. This includes initiatives focused on MyImmune (NK cells), CAR-T cells, COVID-19 mRNA vaccine, diabetes therapeutics, and advancements in stem cell technologies such as induced Pluripotent Stem Cells (iPSCs) and messenger ribonucleic acid (mRNA) platform technology. The Company provides aesthetic treatments, cosmetic procedures, general healthcare and wellness services. The Company’s aesthetic services and cosmetic surgery services include non-surgical aesthetic services and surgical aesthetic services. It operates a molecular laboratory and a cGMP cell and gene therapy research and cultivation laboratory.